Shattuck Labs Inc - ESG Rating & Company Profile powered by AI
If you work at Shattuck Labs Inc and you wish to licence your ESG aseessment, please get in touch. This webpage includes a Q&A table on Shattuck Labs Inc. The analysis of Shattuck Labs Inc leverages data from across the internet as well as from public documents by Shattuck Labs Inc.
Shattuck Labs Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.7; made up of an environmental score of 6.0, social score of 8.0 and governance score of 3.2.
5.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
541 | Wntresearch AB | 5.8 | High |
541 | Zenotech Laboratories Ltd | 5.8 | High |
579 | Shattuck Labs Inc | 5.7 | High |
579 | Caplin Point Laboratories Ltd | 5.7 | High |
579 | Biotest AG | 5.7 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Shattuck Labs Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Shattuck Labs Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Shattuck Labs Inc report the average age of the workforce?
Sign up for free to unlockDoes Shattuck Labs Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Shattuck Labs Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Shattuck Labs Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Shattuck Labs Inc offer flexible work?
Sign up for free to unlockDoes Shattuck Labs Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Shattuck Labs Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Shattuck Labs Inc conduct supply chain audits?
Sign up for free to unlockDoes Shattuck Labs Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Shattuck Labs Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Shattuck Labs Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Shattuck Labs Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Shattuck Labs Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Shattuck Labs Inc disclose water use targets?
Sign up for free to unlockDoes Shattuck Labs Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Shattuck Labs Inc have a product recall in the last two years?
Sign up for free to unlockDoes Shattuck Labs Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Shattuck Labs Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Shattuck Labs Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Shattuck Labs Inc disclose parental leave metrics?
Sign up for free to unlockDoes Shattuck Labs Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Shattuck Labs Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Shattuck Labs Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Shattuck Labs Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Shattuck Labs Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Shattuck Labs Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Shattuck Labs Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Shattuck Labs Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Shattuck Labs Inc disclose its waste policy?
Sign up for free to unlockDoes Shattuck Labs Inc report according to TCFD requirements?
Sign up for free to unlockDoes Shattuck Labs Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Shattuck Labs Inc disclose energy use targets?
Sign up for free to unlockDoes Shattuck Labs Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Shattuck Labs Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Shattuck Labs Inc
These potential risks are based on the size, segment and geographies of the company.
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also holds a collaboration agreement with Takeda Pharmaceuticals to develop SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.